Sentence examples for anticancer data from inspiring English sources
Despite such promising in vitro anticancer data, recent in vivo studies have reported contradictory results regarding genistein's effects on metastasis.
We calculated the MCS between 1000 randomly selected pairs of compounds from the NCI anticancer data which had on average 24 non-hydrogen atoms and 27 bonds.
The two compounds were selected for five-dose assay; these compounds are given in Table 2. Anticancer data reveals that compound 7 shows the growth percent ranges between 25.58 and 112.94, and the most sensitive cell lines are BT-549 (breast cancer) and T-47D (breast cancer) with the cell proliferation of 25.58 and 36.56, respectively.
Overall, the scaffold-diversity assessments measured with scaffold counts and CSR curves were in agreement showing that the anticancer drugs data set was the most diverse (despite it being the smallest data set), whilst the GRAS and GRAS subset data sets were the least diverse.
The recently introduced systemic anticancer therapy data set (National Cancer Intelligence Network (hosted by Public Health England), 2011), linked with the NLCA will provide more detailed real-life data, which will help us to address these important questions.
The observed anticancer screening data of the compounds are given in Table 2.
Although the principles of pharmacogenomic modelling are not new, this study represents novelty in the field, as, to our knowledge, it is the first effort to combine large-scale NCI anticancer screening data using the NCI60 panel with the available cell line profiling information, including error bars.
The addition of anti-IL-6 to doxorubicin or to radiations did not further decrease SOCS3 mRNA level as compared to anticancer treatments alone (data not shown).
Four compounds in M4 showed strong synergism in anticancer action by data analysis.
RG provided assistance in evaluation of the anticancer activity and data interpretaion.
In this review, we have summarized population PKPD modelling analyses describing tumour, tumour marker and biomarker responses, as well as adverse effects, from anticancer drug treatment data.
